➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Medtronic
Express Scripts
Colorcon
Boehringer Ingelheim

Last Updated: September 23, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RIDAURA

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Ridaura

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01419691 ↗ Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) Completed Kansas Bioscience Authority Phase 2 2011-09-01 The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL).
NCT01419691 ↗ Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) Completed The Leukemia and Lymphoma Society Phase 2 2011-09-01 The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL).
NCT01419691 ↗ Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL) Completed Therapeutics for Rare and Neglected Diseases (TRND) Phase 2 2011-09-01 The purpose of this study is to evaluate the safety and effectiveness of auranofin to treat patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or prolymphocytic lymphoma (PLL).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ridaura

Condition Name

Condition Name for Ridaura
Intervention Trials
Recurrent Non-Small Cell Lung Carcinoma 1
Squamous Cell Lung Carcinoma 1
HIV 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Ridaura
Intervention Trials
Carcinoma, Non-Small-Cell Lung 2
Ovarian Neoplasms 2
Lung Neoplasms 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ridaura

Trials by Country

Trials by Country for Ridaura
Location Trials
United States 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Ridaura
Location Trials
Minnesota 3
Florida 2
Arizona 1
Kansas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ridaura

Clinical Trial Phase

Clinical Trial Phase for Ridaura
Clinical Trial Phase Trials
Phase 2 2
Phase 1/Phase 2 2
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Ridaura
Clinical Trial Phase Trials
Active, not recruiting 2
Recruiting 2
Withdrawn 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ridaura

Sponsor Name

Sponsor Name for Ridaura
Sponsor Trials
Mayo Clinic 5
National Cancer Institute (NCI) 4
Vaccine and Gene Therapy Institute, Florida 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Ridaura
Sponsor Trials
Other 10
NIH 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Johnson and Johnson
McKinsey
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.